Internal Medicine, Geriatric Medicine · Pasadena, CA
NPI
1811925183
Since 2006
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2319 E Washington Blvd, Suite 2
Pasadena, CA, 91104
Phone (626) 797-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
130,871 services
Medicare patients, 2024
605
Average age 75
Drug cost, 2024
$3.3M
11,696 prescriptions
Company payments, 2025
$3,550
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen D Henry was code J3121 (injection, testosterone enanthate, 1 mg), 86,385 times for 33 patients. In total Stephen D Henry billed 130,871 services in 183 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3121 Injection, testosterone enanthate, 1 mg | Office | 86,385 | 33 | $0.04 | $3,205 |
| J1306 Injection, inclisiran, 1 mg | Office | 19,028 | 33 | $9.53 | $181K |
| 99214 Office E&M - Established | Office | 2,198 | 536 | $104.66 | $230K |
| 36415 Venipuncture Blood Collection | Office | 2,061 | 540 | $8.65 | $18K |
| 96372 Injection Administration | Office | 2,043 | 228 | $12.09 | $25K |
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 17 | $20.72 | $35K |
| 99211 Office E&M - Established | Office | 1,562 | 492 | $18.74 | $29K |
| U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 1,277 | 480 | $50.28 | $64K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 1,272 | 106 | $0.36 | $454 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,125 | 21 | $0.10 | $117 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,038 | 431 | $13.53 | $14K |
| 99215 Office E&M - Established | Office | 976 | 523 | $145.46 | $142K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 878 | 116 | $0.77 | $676 |
| 99213 Office E&M - Established | Office | 774 | 379 | $72.04 | $56K |
| 81000 Clinical Chemistry | Office | 679 | 434 | $3.94 | $2,675 |
By year: 2022 $1.1M for 106,108 services; 2023 $868K for 127,465 services; 2024 $1.1M for 130,871 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,061 | 540 | $8.65 | $18K |
| U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,277 | 480 | $50.28 | $64K |
| 81000 Clinical Chemistry | 679 | 434 | $3.94 | $2,675 |
| 87804 Immunoassay | 500 | 179 | $16.22 | $8,110 |
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 381 | 381 | $17.69 | $6,740 |
| 87426 Immunoassay | 351 | 210 | $34.62 | $12K |
| 87880 Immunoassay | 31 | 27 | $16.20 | $502 |
| 82274 Immunoassay | 29 | 28 | $15.60 | $452 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen D Henry prescribed most often to Medicare patients was Rosuvastatin Calcium, with 798 prescriptions and refills. In total Stephen D Henry wrote 11,696 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 798 | 2,190 | 219 | $11K |
| Xarelto Rivaroxaban | 556 | 816 | 102 | $440K |
| Gabapentin Generic | 441 | 694 | 86 | $9,434 |
| Atorvastatin Calcium Generic | 410 | 1,112 | 109 | $3,698 |
| Synthroid Levothyroxine Sodium | 266 | 595 | 58 | $27K |
| Ezetimibe Generic | 258 | 722 | 70 | $8,724 |
| Ozempic Semaglutide | 255 | 303 | 39 | $278K |
| Duloxetine Hcl Generic | 235 | 512 | 48 | $5,338 |
| Pantoprazole Sodium Generic | 202 | 479 | 55 | $2,683 |
| Quetiapine Fumarate Generic | 166 | 240 | 35 | $3,582 |
| Amlodipine Besylate Generic | 162 | 454 | 46 | $1,037 |
| Bupropion Xl Bupropion Hcl | 144 | 356 | 34 | $4,194 |
| Eliquis Apixaban | 143 | 199 | 29 | $112K |
| Levothyroxine Sodium Generic | 139 | 345 | 40 | $1,523 |
| Repatha Sureclick Evolocumab | 135 | 191 | 23 | $106K |
Brand drugs: 3,087 claims; generic drugs: 8,506 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen D Henry $3,550 ($3,550 in general payments such as food, travel and fees) from 32 companies. The largest payer was Abbvie Inc. with $432.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $432 |
| Amgen Inc. AMGN | 22 | $294 |
| Bausch Health US, LLC BHC | 18 | $260 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $259 |
| Axsome Therapeutics, Inc. AXSM | 10 | $258 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $241 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $214 |
| Gilead Sciences, Inc. GILD | 9 | $159 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $152 |
| Genzyme Corporation SNY | 3 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.